Cases of 3 Debarred Pharmaceutical Executives Combined
The closely watched case of Howard Udell, the first general counsel of a major company known to be debarred from doing business with federal agencies, has been moved to U.S. District Court in Washington, D.C., and combined with the cases of two of Udell's fellow executives -- chief executive Michael Friedman and chief medical officer Paul D. Goldenheim -- caught up in the same scandal. The cases stem from a May 2007 settlement over the misbranding of the powerful painkiller OxyContin.
